Clobazam – Risk of Drug Reaction With Eosinophilia and Systemic Symptoms (Dress)

Home > Clobazam – Risk of Drug Reaction With Eosinophilia and Systemic Symptoms (Dress)

27 Mar Clobazam – Risk of Drug Reaction With Eosinophilia and Systemic Symptoms (Dress)

Posted at 08:53h in by

The following pharmaceutical companies, Equity Pharmaceuticals (Pty) Ltd, Pharmacare Ltd t/a Aspen Pharmacare and Adcock Ingram Limited in collaboration with the South African Health Products Regulatory Authority (SAHPRA), would like to inform you about the potential risk of drug reaction with eosinophilia and systemic symptoms (DRESS) associated with the use of clobazam­containing medicines.

Download latest version
Document Number: DHCPL
Version: 1
Date Updated: 27/03/2026
File Type: www
Category: Communication To Health Care Professionals
Unit: Pharmacovigilance